| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,091 | 8,576 | 8,321 | 8,439 | | Cost of Revenue | 1,547 | 1,786 | 2,070 | 2,385 | | | Gross Profit |
-
| 6,790 | 6,251 | 6,054 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,726 | 3,908 | 3,947 | 3,556 | | Non Recurring |
-
| 23 |
-
| 10,996 | | Others | 430 | 620 | 170 | (3,680) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,239 | 2,134 | (4,818) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,373 | 2,239 | 2,134 | (4,818) | | Interest Expense | 858 | 889 | 998 | 1,067 | | Income Before Tax | 1,515 | 1,351 | 1,136 | (5,886) | | Income Tax Expense | 513 | 456 | 354 | (2,513) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,002 | 894 | 782 | (3,373) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,002 | 894 | 782 | (3,373) | | Preferred Stock And Other Adjustments | (132) | (132) | (119) |
-
| | | Net Income Applicable To Common Shares | $870 | $763 | $663 | ($3,373) |
|
0.26% Nasdaq 0.00%
Income Statement
